Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NICARDIPINE HYDROCHLORIDE USP, with a corresponding US DMF Number 39326.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 01, 2024, and payment made on February 21, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II